DRONE - Drug Repurposing fOr Neurological disEases

1. Professor Alberto Ascherio will be awarded honorary doctorate at a ceremony to be held in the University Aula on May 24^th🎉 His collaboration with the University of Bergen began many years ago when Ascherio was introduced to Professor Trond Riise, and the two began exploring the causes of MS. Connection to Bergen has strengthened over time, largely thanks to Kjetil Bjørnevik and Marianna Cortese 
2. Dagbladet (Norwegian newspaper) has interviewed Julia Romanowska: "Study: Linking Parkinson's to drug use." 
3. New article with Julia Romanowska first author i Neurology: Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study 
4. NEW article from PhD Candidate Akash Kapali: Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study
5. Master's student Muhammad Eid passed his master's exam on June 14! DRONE congratulates Muhammad!
6. NEW article from PhD Candidate Julia Axiina Tuominen: Beta2-adrenoreceptor agonists and long-term risk of Parkinson's disease
7. DRONE group had a one-day long seminar at Augustin Hotel 17th November 2022
8. DRONE welcome Muhammad Eid, MSc Global Health student at The University of Bergen!
9. Asieh Abolpour Mofrad will defend her dissertation on 15.11.2021 for the PhD degree at the University of Bergen with the dissertation "Clique-Based Neural Associative Memories".
10. September 16th 2021 14:00-14:45: Trial lecture - PhD Asieh Abolpour Mofrad
11. August 2021: Asieh Abolpour Mofrad has started in DRONE - welcome!
12. April 2021: Hopefully a DRONE seminar will be arranged at Solstrand 26-27 May!
13. March 2021: We are looking forward to Asieh Abolpour Mofrad starting with us in August as a postdoctoral fellow! 
14. Sept. 2020: Welcome to two new PhD students, Julia Tuominen and Akash Kapali!
15. Sept. 2020: We have received extra funding from ALS patients’ association (Alltid Litt Sterkere)! This will help us dedicate a full PhD-position to research on this disease.

• Julia Romanowska presented "EXPLORING DRUG REPURPOSING APPROACHES FOR PARKINSON’S DISEASE" at TRACE - opening seminar 19th February 2024.

• Trond Riise presented at a conference in Italy 16th November 2023:  "Use of Artificial Intelligence on registry data to screen for repurposing drugs in neurodegenerative diseases" Conference webpage (italian):  https://snoitalia.org/xvii-convegno-nazionale-di-neuroepidemiologia-ainep-artificial-intelligence-neurologia-e-nuova-era-epidemiologica/

• Julia Romanowska presented "Drug-wide study associates 31 drug classes with the risk of Parkinson's disease" at "The 29^th Norwegian Epidemiological Association (NOFE) conference in Trondheim (15^th to 16^th November 2023)" 

• Akash Kapali presented MoBa findings at MSMilan2023 - world’s largest research meeting in multiple sclerosis held 11-13 October at Allianz MiCo in Milan. "Dietary vitamin D and the risk of multiple sclerosis in the Norwegian Mother and Child cohort" (oral presentation) 
  Multiple Sclerosis Journal. 2023;29(3_suppl):4-136. doi:10.1177/13524585231196191

• Neuro-SysMed Annual Symposium 2023, September 25-26, 2023 Solstrand, Norway: 
  Julia Axiina Tuominen presented with the title: «Medication use after diagnosis and Parkinson’s disease survival: A target trial approach”. See Dagens medisin
  Akash Kapali presented with the title: “Dietary vitamin D and the risk of multiple sclerosis in the Norwegian Mother, Father and Child cohort” See Dagens medisin. 

• Muhammad gave two presentations about his master project at the German Center for Neurodegenerative Diseases (DZNE) and at the FEST Seminar.

• Trond was presenting DRONE at Datathon (https://www.eitrilab.no/datathon2022) and will be presenting at https://www.uib.no/ai/157424/uib-ai-4-examples-medical-ai

• Akash was attending ECTRIMS (26-28 Oct., https://2022.ectrims-congress.eu/)

• Muhammad and Jannicke were attending NOFE (http://nofe.no/nofe-conference-2022/)

• Julia T.: 2022 ANNUAL MEETING – THE GREAT NEURO REUNION  Seattle this April 2-7 (S12 - NEUROEPIDEMIOLOGY 02:48 PM - 03:00 PM PDT Abstract 010 - Selective ß2-Adrenoreceptor Agonists and Long-Term Parkinson’s Disease Risk Julia Axiina Tuominen, MPsych)
• Julia T.: Poster: "Definition and Incidence of Parkinson’s Disease Based on Nationwide Prescription- and Diagnostic Data" at XXV World Congress of Neurology (3-7. October 2021)
• Trond: Abstract "A reverse translational research project for identifying new treatments for Parkinson’s disease: The Italian/Norwegian drug-screening project" at XVI Convegno Nazionale di Neuroepidemiologia 2021 (24. Sept 2021)
• Julia R.: R-Medicine Diving into Registry Data: Using R for Large Norwegian Health Registries (https://r-medicine.org/schedule/) (Thursday, August 26th 2021)
• Julia R.: Bioinformatics in Bergen (18-19. Aug. 2021)
• Julia R.: CEDAS Diving into registry data (https://cedasconf.w.uib.no/accepted-posters/) (1-2. June 2021)

• Marianna Cortese

• Kjetil Lauvland Bjørnevik

• Clemens Scherzer

• Kjell-Morten Myhr

Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study. Kapali A, Daltveit AK, Myhr KM, Bjornevik K, Baldin E, Pugliatti M, Riise T, Cortese M.J Neurol Neurosurg Psychiatry. 2023 Dec 14;95(1):8-13.

Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study. Romanowska J, Bjornevik K, Cortese M, Tuominen JA, Solheim M, Abolpour Mofrad A, Igland J, Scherzer CR, Riise T.Neurology. 2023 Nov 21;101(21):e2068-e2077.

Beta2-adrenoreceptor agonists and long-term risk of Parkinson's disease. Tuominen JA, Bjørnevik K, Romanowska J, Solheim MH, Grydeland TB, Cortese M, Scherzer CR, Riise T, Igland J.Parkinsonism Relat Disord. 2023 May;110:105389. 

Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy. Eid K, Torkildsen Ø, Aarseth J, Celius EG, Cortese M, Holmøy T, Kapali A, Myhr KM, Torkildsen CF, Wergeland S, Gilhus NE, Bjørk MH.J Neurol. 2022 Nov;269(11):5901-5909.